Yaroslau Compta

TL;DR: Nonmotor symptoms (NMS) in Parkinson's disease (PD) are common in early unmedicated PD and frequently reported to occur in the premotor period, but a patient subgroup showed high NMS burden mainly resulting from cognition‐related symptoms.

TL;DR: The features of a novel neurological syndrome associated with prominent sleep dysfunction and antibodies to a neuronal antigen are described and pathological features suggesting a tauopathy are described.

TL;DR: Differential connectivity changes affecting the networks evaluated are demonstrated, which are hypothesize to be related to the pathophysiological bases of different types of cognitive impairment in PD.

TL;DR: Defining cell-specific stages of tau pathology helps to identify preclinical or early-stage cases for the better understanding of early pathogenic events, has implications for understanding the clinical subtype-specific dynamics of disease-propagation, and informs tau-neuroimaging on distribution patterns.

TL;DR: Progressive supranuclear palsy is a neuropathologically defined disease presenting with a broad spectrum of clinical phenotypes, and there is no known cure for this disease.